Aventura Equities Signs Definitive Agreement to Acquire Medical Marijuana Research Company
27 February 2014 - 2:52AM
Marketwired
Aventura Equities Signs Definitive Agreement to Acquire Medical
Marijuana Research Company
GEORGETOWN, SC--(Marketwired - Feb 26, 2014) - Aventura
Equities, Inc.'s (OTC Pink: AVNE) board of directors have signed a
definitive agreement to acquire all of the outstanding stock of
Aventura Laboratories, Inc. from iEquity, Corp. as part of a share
exchange agreement.
"As previously stated, the board of directors announced an
aggressive direction that the Company was going to take concerning
business opportunities, joint ventures or acquisitions," stated Mr.
Richard Armstrong, Chief Executive Officer and director of the
Company. "We believe that our loyal shareholders will now have an
opportunity to participate in an industry sector that will reward
their patience," Mr. Armstrong added.
The definitive agreement calls for some "closing documents" to
be delivered by both parties which the Company expects to be
complete over the next 30 days.
About Aventura
Laboratories, Inc.
Aventura Laboratories, Inc. holds cannabis-related intellectual
property and licensing rights to a number of products currently
sold by third parties in the California medical marijuana market.
The licenses that Aventura Laboratories currently holds include;
Dharmanol, Yak Capsules, Yeti Honeybud Oilers, Organakoil, Red
Diamond Oil, and other products, trademarks, formulations, and
trade secrets that are licensed to SK3 Group's wholesale managed
collectives.
In addition, Adventura Laboratories holds the intellectual
property resulting from research conducted by Berkeley Bio Organic
Research Laboratory. Current and continuing research includes
research into mixed phyto-cannabinoid carboxylates, decarboxylation
processes, and cannabidiol (CBD) extraction methods.
About iEquity
Corp.
iEquity, Corp creates, acquires and develops companies and
projects in the medical cannabis space. Currently, iEquity Corp
holds controlling interest and retains intellectual properties and
contracts in several medical marijuana companies and related
projects. More information is available at: www.iequitycorp.com
Disclaimer: Forward Looking Statements
This release contains statements relating to future results
which are forward-looking statements. These statements are not
historical facts and are not guaranteed, but instead represent only
the good faith belief of AVNE management as of the date of this
release. Future events are by their nature inherently
uncertain and outside of AVNE's control. It is possible that AVNE's
actual results and financial condition may differ, possibly
materially, from the anticipated results and financial condition
indicated in these forward-looking statements. Forward-looking
statements in this release are made pursuant to the safe harbor
provisions of securities laws in force as of the date of this
release. AVNE does do not undertake any obligation to publicly
update or correct any forward-looking statements to reflect events
or circumstances that subsequently occur or of which we hereafter
become aware.
Contact: Richard Armstrong Chief Executive Officer 803-230-8487
ricka@rwenergies.com www.rwenergies.com
Aventura Equities (CE) (USOTC:AVNE)
Historical Stock Chart
From Nov 2024 to Dec 2024
Aventura Equities (CE) (USOTC:AVNE)
Historical Stock Chart
From Dec 2023 to Dec 2024
